William Woods
Stock Analyst at B. Riley Securities
(0.61)
# 4,123
Out of 5,124 analysts
12
Total ratings
30.77%
Success rate
-15.04%
Average return
Main Sectors:
Stocks Rated by William Woods
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| PALI Palisade Bio | Initiates: Buy | $7 | $1.64 | +326.83% | 1 | Jan 9, 2026 | |
| MDGL Madrigal Pharmaceuticals | Maintains: Buy | $560 → $670 | $477.60 | +40.28% | 1 | Dec 11, 2025 | |
| OKYO OKYO Pharma | Initiates: Buy | $5 | $1.92 | +160.42% | 1 | Dec 8, 2025 | |
| CGTX Cognition Therapeutics | Reiterates: Buy | $2 → $3 | $1.06 | +183.02% | 1 | Nov 21, 2025 | |
| LFMD LifeMD | Maintains: Buy | $12 → $10 | $3.14 | +218.47% | 3 | Nov 18, 2025 | |
| IMUX Immunic | Reiterates: Buy | $6 → $5 | $0.62 | +706.45% | 3 | May 23, 2025 | |
| VERU Veru Inc. | Initiates: Buy | $50 | $2.34 | +2,036.75% | 1 | May 14, 2024 | |
| KRMD KORU Medical Systems | Reiterates: Buy | $4 | $4.92 | -18.70% | 1 | Mar 14, 2024 |
Palisade Bio
Jan 9, 2026
Initiates: Buy
Price Target: $7
Current: $1.64
Upside: +326.83%
Madrigal Pharmaceuticals
Dec 11, 2025
Maintains: Buy
Price Target: $560 → $670
Current: $477.60
Upside: +40.28%
OKYO Pharma
Dec 8, 2025
Initiates: Buy
Price Target: $5
Current: $1.92
Upside: +160.42%
Cognition Therapeutics
Nov 21, 2025
Reiterates: Buy
Price Target: $2 → $3
Current: $1.06
Upside: +183.02%
LifeMD
Nov 18, 2025
Maintains: Buy
Price Target: $12 → $10
Current: $3.14
Upside: +218.47%
Immunic
May 23, 2025
Reiterates: Buy
Price Target: $6 → $5
Current: $0.62
Upside: +706.45%
Veru Inc.
May 14, 2024
Initiates: Buy
Price Target: $50
Current: $2.34
Upside: +2,036.75%
KORU Medical Systems
Mar 14, 2024
Reiterates: Buy
Price Target: $4
Current: $4.92
Upside: -18.70%